Literature

HOME > Literature

2012

2011

2010

  • Evaluation of responses to IVIG therapy in patients with severe Sepsis and septic shock by soluble CD14 subtype monitoring.
    Takahashi G, Suzuki Y, Kojika M, Matsumoto N, Shozushima T, Makabe H, Yamada Y, Shioya N, Shibata S, Shirakawa K, Endo S
    Medical Postgraduates 48; 19-24, 2010
  • Assessment of the usefulness of the soluble CD14 subtype and the point of care test in septic patients
    Takahashi G, Suzuki Y, Kojika M, Shozushima T, Matsumoto N, Kikkawa T, Hoshikawa K, Akitomi S, Shibata S, Aoki K, Inoue Y, Shirakawa K, Endo S
    Medical Postgraduates 48; 15-18, 2010
  • Serum levels of soluble CD14 subtype reflect the APACHE II and SOFA scores
    Kojika M, Takahashi G, Matsumoto N, Kikkawa T, Hoshikawa K, Shioya N, Suzuki Y, Aoki H, Shirakawa K, Endo S
    Medical Postgraduates 48; 46-50. 2010
  • Severity assessment of sepsis by determination of the soluble CD14 subtype using the POC test
    Takahashi G, Suzuki Y, Kojika M, Matsumoto N, Kikuchi S, Shozushima T, Onodera C, Masuda T, Sato H, Shioya N, Shibata S, Endo S
    Medical Postgraduates 48; 25-27. 2010
  • Evaluations of PRESEPSIN by a Point-of-Care Test (POC Test) Closely Reflect the Efficacy of Polymyxin-B Immobilized Fiber-Direct Hemoperfusion (PMX-DHP): A Case Report
    Shozushima T, Kojika M, Takahashi G, Kikkawa T, Hoshikawa K, Kan S, Onodera C, Matsumoto N, Suzuki Y, Endo S
    J Iwate Med Assoc 62; 411-416, 2010

2005